Alnylam Europe competitive analysis

Latest publications and patents of Alnylam Europe New

Explore the latest publications and patents granted to Alnylam Europe, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Alnylam Europe

Mar 15, 2017Methods And Medicament For Inhibition The Expression Of A Defined GeneRevoked

Explore Alnylam Europe's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 15, 2017Methods And Medicament For Inhibition The Expression Of A Defined Gene1

Latest PTAB cases involving Alnylam Europe

Discover the latest PTAB cases involving Alnylam Europe, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Alnylam Europe with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ALNYLAM EUROPE - 1 - - Non-Active
SILENCE THERAPEUTICS28 - 5Defensive